Cancer Treatment Registry



Category: Adjunctive to Chemo & Radiation

Neutropenic patients can receive blood cell boosters (growth factors) such as Neulasta or Neupogen® (filgrastim), which are given by injection during chemotherapy cycles. Neulasta and Neupogen have demonstrated the ability to reduce infections, hospitalizations, medical cost, dose delays, and death associated with infection in neutropenic patients. The FDA has approved Neulasta (a longer-acting form of Neupogen) to be given 14 days before initiation of chemotherapy or at least 24 hours following initiation of chemotherapy (however, this requires patients to return to the medical office or hospital one day following chemotherapy for administration).

Google it: Neulasta

Add A Comment


Newest Member   User name: JohnD
  Location: Add Other Location     
  Washington, 98382 Age: 70

Newest Treatment MSQ Nutritional Therapy
Type: Nutritional

Most Viewed IP6
Type: Nutritional

Most Used Treatment Chemotherapy
Type: Chemotherapy

Home View-Patients View-Treatments View-Statistics View-Doctors Sitemap Sponsors Contact